LCAT and metabolic dysfunction-associated steatotic liver disease: In models of NAFLD-associated HCC, LCAT deficiency exacerbates lipid droplet formation and promotes a tumorigenic microenvironment through oxysterol-mediated LXRα activation [39, 40].